Cynthia Collins

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Codexis, Inc. publishes a filing, an earnings call transcript or a press release.

Get CDXS alerts

About Cynthia Collins

Cynthia Collins is recorded as Board Member at Codexis, Inc. (CDXS) since January 1, 2025. The newest filing on record that lists Cynthia Collins as Board Member at Codexis, Inc. (CDXS) is dated April 28, 2026. Earlier roles on record: CEO at Editas Medicine, Inc. (EDIT) until February 15, 2021. Codexis, Inc. reported in an 8-K filed March 31, 2025 that Cynthia Collins was appointed member of the Board as a Class II director, effective March 28, 2025. The proxy statement of Editas Medicine, Inc. reports total compensation of $14,489,736 for Cynthia Collins in fiscal 2019, including a base salary of $909,174. Codexis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Codexis, Inc. includes Alison Moore (CEO and Board Member), Alison Moore, Ph.D. (CEO and CTO), Dr. Stephen Dilly (CEO) and 7 others.

“On March 28, 2025, the Board of Directors (the "Board") of Codexis, Inc. (the "Company"), upon the recommendation of the Board's Nominating and Corporate Governance Committee, appointed Cynthia Collins as a member of the Board as a Class II director, effective immediately.”

Codexis, Inc. Form 8-K, filed March 31, 2025 · Read the filing

Affiliation history

Codexis, Inc. (CDXS)
Board Member

Proxy statement

Current
2025-01-01–present

Last confirmed April 28, 2026
Editas Medicine, Inc. (EDIT)
CEO

Source not stated

Start not stated–2021-02-15